Application of nanogel systems in the administration of local anesthetics

Local and Regional Anesthesia

Volumn 3, Issue 1, 2010, Pages 93-100

  Tan, Jeremy P K ^a   Tan, Maureen B H ^b   Tam, Michael K C ^c  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b INSTITUTE OF MATERIALS RESEARCH AND ENGINEERING   (Singapore)

^c UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Active drug compounds; Local anesthetics; Nanogels; Nanoparticles; Polymeric nanoparticles; Procaine hydrochloride (prhy)

Indexed keywords

ACRYLIC ACID ETHYL ESTER; ACRYLIC ACID METHYL ESTER; BUPIVACAINE; NANOGEL; NANOMATERIAL; NANOSPHERE; POLYGLACTIN; PROCAINE; UNCLASSIFIED DRUG;

ATOM TRANSFER RADICAL POLYMERIZATION; BINDING AFFINITY; CROSS LINKING; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SYNTHESIS; ENCAPSULATION; LOCAL ANESTHESIA; MOLECULAR INTERACTION; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; REVIEW;

EID: 77957294817     PISSN: None     EISSN: 11787112     Source Type: Book Series    
DOI: 10.2147/LRA.S7977     Document Type: Review

References (71)

1. Bruguerolle B, Labrecque G. Rhythmic pattern in pain and their chronotherapy. Adv Drug Deliv Rev. 2007;59:883-895.
2. Bourne E, Wright C, Royse C. A review of local anesthetic cardiotoxicity and treatment with lipid emulsion. Local Reg Anesth. 2010; 3:11-19.
3. Albright G. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology. 1979;51:285-287.
4. Trachez MM, Zapata-Sudo G, Moreira OR, et al. Motor nerve blockade potency and toxicity of non-racemic bupivacaine in rats. Acta Anaesthesiol Scand. 2005;49:66-71.
5. Zapata-Sudo G, Trachez MM, Sudo RT, Nelson TE. Is comparative cardiotoxicity of S(-) and R(+) bupivacaine related to enantiomerselective inhibition of L-type Ca(2+) channels? Anesth Analog. 2001;92: 496-501.
6. Görner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Control Release. 1999; 57:259-268.
7. Soppimath KS, Aminabhavi TM, Kulkarni AR, Dudziski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1-20.
8. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology. 1998;88:1071-1075.
9. Weinberg G, Ripper R, Feinstein DL, Hoffman W. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med. 2003;28:198-202.
10. Pinto LMA, Yokaichiya DK, Fraceto LF, de Paula E. Interaction of benzocaine with model membranes. Biophys Chem. 2000;87:213-223.
11. Kohane DS, Lipp M, Kinney RC, Lotan N, Langer R. Sciatic nerve blockade with lipid-protein-sugar particles containing bupivacaine. Pharm Res. 2000;17:1243-1249.
12. Pinto LMA, Fraceto LF, Santana MHA, Pertinhez TA, Junior SO, de Paula E. Physico-chemical characterization of benzocaine-β- cyclodextrin inclusion complexes. J Pharm Biomed Anal. 2005;39: 956-963.
13. Blanco MD, Bernardo MV, Sastre RL, Olmo R, Muniz E, Teijón JM. Preparation of bupivacaine-loaded poly(ε-caprolactone) microspheres by spray drying: drug release studies and biocompatibility. Eur J Pharm Biopharm. 2003;55:229-236.
14. Corre PL, Estèbe JP, Clément R, et al. Spray-dryed bupivavaine-loaded microspheres: in vitro eveluation and biopharmaceutics of bupivacaine following brachial plexus adminintration in sheep. Int J Phram. 2002; 238:191-203.
15. Tomoda K, Asahiyama M, Ohtsuki E, et al. Preparation and properties of carrageenan microspheres containing allopurinol and local anesthetic agents for the treatment of oral mucositis. Colloids Surf B Biointerfaces. 2009;71:27-35.
16. Bernardo MV, Blanco MD, Olmo R, Teijón JM. Delivery of bupivacaine included in poly(acrylamide-co-monomethyl itaconate) hydrogels as a function of the pH swelling medium. J Appl Polym Sci. 2002;86: 327-334.
17. Moraes CM, de Lima R, Rosa AH, de Paula E, Fraceto LF. Encapsulation of local anesthetic bupivacaine in biodegrable poly (DL-lactide-co-glycolide) nanospheres: factorial design, characterization and cytotoxicity studies. Macromol Symp. 2009;281:106-112.
18. Moraes CM, de Matos AP, de Lima R, Rosa AH, de Paula E, Fraceto LF. Initial development and characterization of PLGA nanospheres containing ropivacaine. J Biol Phys. 2007;33:455-461.
19. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release. 1999;57:171-185.
20. Tan JPK, Goh CH, Tam KC. Comparative drug release studies of two cationic drugs from pH-responsive nanogels. Eur J Pharm Sci. 2007; 32:340-348.
21. Kumar MNVR, Kumar N, Domb AJ, Arora M. Pharmaceutical polymeric controlled drug delivery systems. Adv Polym Sci. 2002;160:45-117.
22. Nayak S, Lyon LA. Soft nanotechnology with soft nanoparticles. Angew Chem Int Ed Engl. 2005;44:7686-7708.
23. Donini C, Robinson DN, Colombo P, Giordano F, Peppas NA. Preparation of poly(methacrylic acid-g-poly(ethylene glycol)) nanospheres from methacrylic monomers for pharmaceutical applications. Int J Pharm. 2002;245:83-91.
24. Pelton RH. Temperature-sensitive aqueous microgels. Adv Colloid Interface Sci. 2000;85:1-33.
25. Pelton RH, Chibante P. Preparation of aqueous lattices with N-isopropylacrylamide. Colloids Surf. 1986;20:247-256.
26. Landfester K, Willert M, Antonietti M. Preparation of polymer particles in nonaqueous direct and inverse miniemulsions. Macromolecules. 2000;33:2370-2376.
27. Kriwet B, Walter E, Kissel T. Synthesis of bioadhesive poly(acrylic acid) nano- and microparticles using an inverse emulsion polymerization method for the entrapment of hydrophilic drug candidates. J Control Release. 1998;56:149-158.
28. Sun Q, Deng Y. In situ synthesis of temperature-sensitive hollow microspheres via interfacial polymerization. J Am Chem Soc. 2005; 127:8274-8275.
29. Neyret S, Vincent B. The properties of polyampholyte microgel particles prepared by microemulsion polymerization. Polymer. 1997;38: 6129-6134.
30. Liu J, Zhang Q, Remsen EE, Wooley KL. Nanostructured materials designed for cell binding and transduction. Biomacromolecules. 2001;2:362-368.
31. Marie E, Rothe R, Antonietti M, Landfester K. Synthesis of polyaniline particles via inverse and direct miniemulsion. Macromolecules. 2003; 36:3967-3973.
32. Murthy N, Xu M, Schuck S, Kunisawa J, Shastri N, Frechet JM. A macromolecular delivery vehicle for protein-based vaccines:acid-degradable proteinloaded microgels. Proc Natl Acad Sci U S A. 2003; 100:4995-5000.
33. Goh SL, Murthy N, Xu M, Frechet JM. Cross-linked microparticles as carriers for the delivery of plasmid DNA for vaccine development. Bioconjug Chem. 2004;15:467-474.
34. Kwon YJ, Standley SM, Goh SL, Frechet JM. Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles. J Control Release. 2005;105: 199-212.
35. Oh JK, Tang C, Gao H, Tsarevsky NV, Matyjaszewski K. Inverse miniemulsion ATRP: a new method for synthesis and functionalization of well-defined water-soluble/cross-linked polymeric particles. J Am Chem Soc. 2006;128:5578-5584.
36. Oh JK, Siegwart DJ, Lee HI, et al. Biodegradable nanogels prepared by atom transfer radical polymerization as potential drug delivery carriers: synthesis, biodegradation, in vitro release, and bioconjugation. J Am Chem Soc. 2007;129:5939-5945.
37. Booth C, Attwood D. Effects of block architecture and composition on the association properties of poly(oxyalkylene) copolymers in aqueous solution. Macromol Rapid Commun. 2000;21:501-527.
38. Riess G. Micellization of block copolymers. Prog Polym Sci. 2003;28: 1107-1170.
39. Zamurovic M, Christodoulou S, Vazaios A, Iatrou E, Pitsikalis M, Hadjichristidis N. Micellization behavior of complex comblike block copolymer architectures. Macromolecules. 2007;40:5835-5849.
40. Castro E, Barbosa S, Juarez J, Taboada P, Katime IA, Mosquera V. Influence of external factors on the micellization process and aggregate structure of poly(oxy)styrene-poly(oxy)ethylene block copolymers. J Phys Chem B. 2008;112:5296-5304.
41. Denkova AG, Mendes E, Coppens MO. Effects of salts and ethanol on the population and morphology of triblock copolymer micelles in solution. J Phys Chem B. 2008;112:793-801.
42. Bang J, Viswanathan K, Lodge TP, Park MJ, Char K. Temperaturedependent micellar structures in poly(styrene-b-isoprene) diblock copolymer solutions near the critical micelle temperature. J Chem Phys. 2004;121:11489-11500.
43. Jansson J, Schillen K, Olofsson G, da Silva RC, Loh W. The interaction between PEO-PPO-PEO triblock copolymers and ionic surfactants in aqueous solution studied using light scattering and calorimetry. J Phys Chem B. 2004;108:82-92.
44. Lin YN, Alexandridis P. Cosolvent effects on the micellization of an amphiphilic siloxane graft copolymer in aqueous solutions. Langmuir. 2002;18:4220-4231.
45. Hennink WE, van Nostrum CF. Novel crosslinking methods to designhydrogels Adv Drug Deliv Rev. 2002;54:13-36.
46. Vinogradov SV, Batrakova EV, Kabanov AV. Poly(ethylene glycol)-polyethyleneimine nanogel particles: novel drug delivery systems for antisense oligonucleotides. Colloids Surf B. 1999;16:291-304.
47. Sun HW, Yu JH, Gong PJ, et al. Novel core-shell magnetic nanogels synthesized in an emulsion-free aqueous system under UV irradiation for potential targeted radiopharmaceutical applications. Int J Nanosci. 2006;5:253-258.
48. Xu DM, Yao SD, Liu YB, et al. Size-dependent properties of M-PEIs nanogels for gene delivery in cancer cells. Int J Pharm. 2007;338:291-296.
49. Gupta M, Gupta AK. In vitro cytotoxicity studies of hydrogel pullulan nanoparticles prepared by aot/n-hexane micellar system. J Pharm Pharm Sci. 2004;7:38-46.
50. Gupta M, Gupta AK. Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier. J Control Release. 2004;99:157-166.
51. Kohli E, Han HY, Zeman AD, Vinogradov SV. Formulations of biodegradable nanogel carriers with 5'-triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activity. J Control Release. 2007;121:19-27.
52. Lee H, Mok H, Lee S, Oh YK, Park TG. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release. 2007;119:245-252.
53. Mok H, Park TG. PEG-assisted DNA solubilization in organic solvents for preparing cytosol specifically degradable PEG/DNA nanogels. Bioconjug Chem. 2006;17:1369-1372.
54. Ma QG, Remsen EE, Kowalewski T, Wooley KL. Two-dimensional, shell-cross-linked nanoparticle arrays. J Am Chem Soc. 2001;123: 4627-4628.
55. Pochan DJ, Chen Z, Cui H, Hales K, Qi K, Wooley KL. Toroidal triblock copolymer assemblies. Science. 2004;306:94-97.
56. Chen Z, Cui H, Hales K, et al. Unique toroidal morphology from composition and sequence control of triblock copolymers. J Am Chem Soc. 2005;127:8592-8593.
57. Harrisson S, Wooley KL. Shell-crosslinked nanostructures from amphiphilic AB and ABA block copolymers of styrene-alt-(maleic anhydride) and styrene: polymerization, assembly and stabilization in one pot. Chem Commun. 2005;26:3259-3261.
58. Joralemon MJ, O'Reilly RK, Hawker CJ, Wooley KL. Shell click-crosslinked (SCC) nanoparticles: a new methodology for synthesis and orthogonal functionalization. J Am Chem Soc. 2005;127:16892-16899.
59. Vinogradov SV, Kohli E, Zeman AD. Comparison of nanogel drug carriers and their formulations with nucleoside 5-triphosphates. Pharm Res. 2006;23:920-930.
60. Lee WC, Li YC, Chu IM. Amphiphilic poly(D,L-lactic acid)/ poly(ethylene glycol)/poly(D,L-lactic acid) nanogels for controlled release of hydrophobic drugs. Macromol Biosci. 2006;6:846-854.
61. Rolland JP, Maynor BW, Euliss LE, Exner AE, Denison GM, DeSimone JM. Direct fabrication and harvesting of monodisperse, shapespecific nanobiomaterials. J Am Chem Soc. 2005;127:10096-10100.
62. Gratton SE, Pohlhaus PD, Lee J, Guo J, Cho MJ, DeSimone JM. Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. J Control Release. 2007; 121:10-18.
63. Lee JM, Park KM, Lim SJ, Lee MK, Kim CK. Microemulsion formulation of clonixic acid: solubility enhancement and pain reduction. J Pharm Pharmacol. 2002;54:43-49.
64. Date AA, Nagarsenker MS. Parenteral microemulsions: an overview. Int J Pharm. 2008;355:19-30.
65. Bruce A, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular Biology of the Cell. New York: Garland; 1994.
66. Tan JPK, Zeng AQF, Chang CC, Tam KC. Release kinetics of procaine hydrochloride (PrHy) from pH-responsive nanogels: theory and experiments. Int J Pharm. 2008;357:305-313.
67. Arifin AD, Lee LY, Wang CH. Mathematical modeling and simulation of drug release from microspheres: implications to drug delivery system. Adv Drug Deliv Rev. 2006;58:1274-1325.
68. Lee W, Park J, Yang EH, et al. Investigation of the factors influencing the release rates of cyclosporine A loaded micro- and nanoparticles prepared by high pressure homogenizer. J Control Release. 2002;84:115-123.
69. Borges O, Silva AC, Romeijn SG, et al. Uptake studies rat Payer's patches, cytotoxicity and release studies of alginated coated chitosan nanoparticles for mucosal vaccination. J Control Release. 2006;114: 348-358.
70. Gu J, Xia F, Wu Y, Qu X, Yang Z, Jiang L. Programmable delivery of hydrophilic drug using dually responsive hydrogel cages. J Control Release. 2007;117:396-402.
71. Tan JPK, Wang Q, Tam KC. Control of burst release from nanogels via layer by layer assembly. J Control Release. 2008;128:248-254.